Dov A Md Goldstein sold $405K of BioAge Labs (BIOA)

Executed Jan 13, disclosed Jan 15, 2 days later.

Value, as filed

$405K

20,637 sh across 2 lots

Executed

Jan 13

the trade date, as filed

Disclosed

Jan 15

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

DG Dov A Md Goldstein Chief Financial Officer profile →

Dov A Md Goldstein (Chief Financial Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in BioAge Labs, Inc. (BIOA). The largest single filing was $405K of BIOA (20,637 sh across 2 lots, as filed), executed Jan 13.

The name

BIOA BioAge Labs, Inc. BIOA · Healthcare · 13 filings in 24 months ticker →

Healthcare · BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→